- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
16
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
16 companies
Madrigal Pharmaceuticals
Market Cap: US$10.6b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$518.76
7D
14.2%
1Y
53.8%
Ascendis Pharma
Market Cap: US$13.6b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$220.60
7D
-1.4%
1Y
39.7%
Insmed
Market Cap: US$32.0b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$147.60
7D
2.5%
1Y
90.0%
Alnylam Pharmaceuticals
Market Cap: US$43.6b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$328.16
7D
5.5%
1Y
21.1%
BridgeBio Pharma
Market Cap: US$13.9b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$72.58
7D
3.6%
1Y
99.4%
BeOne Medicines
Market Cap: US$31.4b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$276.95
7D
-2.0%
1Y
5.5%
Ionis Pharmaceuticals
Market Cap: US$12.0b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$74.24
7D
4.1%
1Y
134.0%
AbbVie
Market Cap: US$366.5b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$211.12
7D
2.4%
1Y
4.1%
Jazz Pharmaceuticals
Market Cap: US$11.6b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$189.15
7D
4.0%
1Y
49.6%
Eli Lilly
Market Cap: US$819.9b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$897.00
7D
-2.2%
1Y
9.2%
BioMarin Pharmaceutical
Market Cap: US$10.7b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$55.55
7D
0.9%
1Y
-23.7%
Natera
Market Cap: US$28.0b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$196.15
7D
-3.2%
1Y
32.3%
Royalty Pharma
Market Cap: US$27.1b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$46.94
7D
3.1%
1Y
48.3%
Viatris
Market Cap: US$15.5b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$13.37
7D
-1.0%
1Y
51.2%
Elanco Animal Health
Market Cap: US$12.7b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$24.58
7D
-2.1%
1Y
127.4%
Waters
Market Cap: US$29.7b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$300.56
7D
0.3%
1Y
-18.9%